The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
Open accessAbstract
Methicillin resistance in staphylococci is determined by mec, composed of 50 kb or more of DNA found only in methicillin-resistant strains. mec contains mecA, the gene for penicillin-binding protein 2a (PBP 2a); mecI and mecR1, regulatory genes controlling mecA expression; and numerous other elements and resistance determinants. A distinctive feature of methicillin resistance is its heterogeneous expression. Borderline resistance, a low-level type of resistance to methicillin exhibited by strains lacking mecA, is associated with modifications in native PBPs, beta-lactamase hyperproduction, or possibly a methicillinase. The resistance phenotype is influenced by numerous factors, including mec and beta-lactamase (bla) regulatory elements, fem factors, and yet to be identified chromosomal loci. The heterogeneous nature of methicillin resistance confounds susceptibility testing. Methodologies based on the detection of mecA are the most accurate. Vancomycin is the drug of choice for treatment of infection caused by methicillin-resistant strains. PBP 2a confers cross-resistance to most currently available beta-lactam antibiotics. Investigational agents that bind PBP 2a at low concentrations appear promising but have not been tested in humans. Alternatives to vancomycin are few due to the multiple drug resistances typical of methicillin-resistant staphylococci.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Hartman, B. J., & Tomasz, A. (1984) · Journal of Bacteriology · doi:10.1128/jb.158.2.513-516.1984 · Cited by 890
Methicillin-resistant staphylococci
Barber, M. (1961) · Journal of Clinical Pathology · doi:10.1136/jcp.14.4.385 · Cited by 729
PENICILLIN-BINDING PROTEINS AND THE MECHANISM OF ACTION OF BETA-LACTAM ANTIBIOTICS
Waxman, D. J., & Strominger, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.004141 · Cited by 721
The staphylococci in human disease
Crossley, K., & Archer, G. L. (1996) · Churchill Livingstone eBooks · Cited by 632
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Cellbenin-resistant staphylococci.
Jevons, M. P. (1961) · Medical Entomology and Zoology · Cited by 555
Evidence for a Clonal Origin of Methicillin Resistance in Staphylococcus aureus
Kreiswirth, B., Kornblum, J., Arbeit, R. D., Eisner, W., Maslow, J. N., McGeer, A., Low, D. E., & Novick, R. P. (1993) · Science · doi:10.1126/science.8093647 · Cited by 409
Crossley, K., Loesch, D., Landesman, B., Mead, K., Chern, M., & Strate, R. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/139.3.273 · Cited by 390
Utsui, Y., & Yokota, T. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.3.397 · Cited by 365
Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343
Matsuhashi, M., Song, M. D., Ishino, F., Wachi, M., Doi, M., Inoue, M., Ubukata, K., Yamashita, N., & Konno, M. (1986) · Journal of Bacteriology · doi:10.1128/jb.167.3.975-980.1986 · Cited by 316
de Jonge, B. L., Chang, Y. S., Gage, D., & Tomasz, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49903-1 · Cited by 315
Song, M. D., Wachi, M., Doi, M., Ishino, F., & Matsuhashi, M. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80373-3 · Cited by 302
SARAVOLATZ, L. D., POHLOD, D. J., & ARKING, L. M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-325 · Cited by 290
Heldman, A. W., Hartert, T. V., Ray, S. C., Daoud, E. G., Kowalski, T. E., Pompili, V. J., Sisson, S. D., Tidmore, W. C., vom Eigen, K. A., Goodman, S. N., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00070-8 · Cited by 289
Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus
Hartman, B. J., & Tomasz, A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.1.85 · Cited by 263
Ubukata, K., Nonoguchi, R., Matsuhashi, M., & Konno, M. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.5.2882-2885.1989 · Cited by 247
Methicillin-Resistant Staphylococcus aureus as a Community Organism
Moreno, F., Crisp, C., Jorgensen, J. H., & Patterson, J. E. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1308 · Cited by 239
Klimek, J. J., Marsik, F. J., Bartlett, R. C., Weir, B., Shea, P., & Quintiliani, R. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90370-3 · Cited by 236
Antibiotic inhibition of bacterial cell surface assembly and function
Actor, P. (1988) · ASM Press eBooks · Cited by 232
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 232
LEVINE, D. P., CUSHING, R. D., JUI, J., & BROWN, W. J. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-330 · Cited by 224
Tomasz, A., Drugeon, H. B., de Lencastre, H. M., Jabes, D., McDougall, L., & Bille, J. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.11.1869 · Cited by 223
Hiramatsu, K. (1995) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1995.tb02239.x · Cited by 206
GROWING CLINICAL SIGNIFICANCE OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Jack Benner, E., & Kayser, F. H. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90947-1 · Cited by 206
Berger-Bächi, B., Barberis-Maino, L., Strässle, A., & Kayser, F. H. (1989) · Molecular and General Genetics MGG · doi:10.1007/bf00261186 · Cited by 202
Strandén, A. M., Ehlert, K., Labischinski, H., & Berger-Bächi, B. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.1.9-16.1997 · Cited by 201
de Lencastre, H., & Tomasz, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.11.2590 · Cited by 199
Vancomycin Resistance: Decoding the Molecular Logic
Walsh, C. T. (1993) · Science · doi:10.1126/science.8392747 · Cited by 194
Hackbarth, C. J., & Chambers, H. F. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1144 · Cited by 191
Self-citationIntrinsic resistance to β‐lactam antibiotics in staphylococcus aureus
Brown, D. F. J., & Reynolds, P. E. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80455-8 · Cited by 187
Wu, S., Piscitelli, C., de LENCASTRE, H., & Tomasz, A. (1996) · Microbial Drug Resistance · doi:10.1089/mdr.1996.2.435 · Cited by 185
Crossley, K., Loesch, D. M., Landesman, B., et al. (1979) · Cited by 185
Maidhof, H., Reinicke, B., Blümel, P., Berger-Bächi, B., & Labischinski, H. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.11.3507-3513.1991 · Cited by 182
Hiramatsu, K., Asada, K., Suzuki, E., Okonogi, K., & Yokota, T. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80039-j · Cited by 182
Beck, W. D., Berger-Bächi, B., & Kayser, F. H. (1986) · Journal of Bacteriology · doi:10.1128/jb.165.2.373-378.1986 · Cited by 176
Molecular aspects of methicillin resistance in Staphylococcus aureus
de LENCASTRE, H., DeJonge, B. L. M., Matthews, P., & Tomasz, A. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.1.7 · Cited by 176
Origin and evolution of DNA associated with resistance to methicillin in staphylococci
Archer, G. L., & Niemeyer, D. M. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90608-4 · Cited by 172
Dworkin, R. J., Sande, M. A., Lee, B. L., & Chambers, H. F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91083-0 · Cited by 170
Self-citationEmergence of Teicoplanin Resistance During Therapy of Staphylococcus aureus Endocarditis
Kaatz, G. W., Seo, S. M., Dorman, N. J., & Lerner, S. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.1.103 · Cited by 166
Evolution of Natural Resistance to the Newer Penicillins
Stewart, G. T., & Holt, R. (1963) · BMJ · doi:10.1136/bmj.1.5326.308 · Cited by 159
Staphylococcus aureus Endocarditis: Combined Therapy With Vancomycin and Rifampin
Faville, R. J. (1978) · JAMA · doi:10.1001/jama.1978.03290180037019 · Cited by 158
Murakami, K., & Tomasz, A. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.2.874-879.1989 · Cited by 158
Dissemination among staphylococci of DNA sequences associated with methicillin resistance
Archer, G. L., Niemeyer, D. M., Thanassi, J. A., et al. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.447 · Cited by 152
Ryffel, C., Kayser, F. H., & Berger‐Bächi, B. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.25 · Cited by 151
(1990) · Infectious Diseases Newsletter · doi:10.1016/0278-2316(90)90059-o · Cited by 151
Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus
Henze, U. U., Sidow, T., Wecke, J., Labischinski, H., & Berger‐Bächi, B. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.6.1612-1620.1993 · Cited by 150
Distribution of mec regulator genes in methicillin-resistant Staphylococcus clinical strains
Suzuki, E., Kuwahara‐Arai, K., Richardson, J. F., & Hiramatsu, K. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1219 · Cited by 144
Suzuki, E., Hiramatsu, K., & Yokota, T. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.429 · Cited by 143
Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus
Ryffel, C., Strässle, A., Kayser, F. H., & Berger‐Bächi, B. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.724 · Cited by 140
Kuwahara‐Arai, K., Kondo, N., Hori, S., Tateda-Suzuki, E., & Hiramatsu, K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2680 · Cited by 136
Chambers, H. F. “., & Sachdeva, M. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.6.1170 · Cited by 130
Self-citationCharacterization of a conjugative staphylococcal mupirocin resistance plasmid
Morton, T. M., Johnston, J. L., PATTERSON, J. E., & Archer, G. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1272 · Cited by 129
Trimethoprim-Sulfamethoxazole for Bacterial Meningitis
Levitz, R. E., & QUINTILIANI, R. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-881 · Cited by 126
Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones
Schaefler, S. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.2.335-336.1989 · Cited by 122
Bacterial Resistance to Fluoroquinolones
Neu, H. C. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.supplement_1.s57 · Cited by 116
Niemeyer, D. M., Pucci, M. J., Thanassi, J. A., Sharma, V. K., & Archer, G. L. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.18.5464-5471.1996 · Cited by 112
Gustafson, J. E., Strässle, A., Hächler, H., Kayser, F. H., & Berger‐Bächi, B. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.5.1460-1467.1994 · Cited by 111
Boyce, J. M., Medeiros, A. A., Papa, E. F., et al. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.1.73 · Cited by 106
Chromosomal map location of the methicillin resistance determinant in Staphylococcus aureus
Kuhl, S. A., Pattee, P. A., & Baldwin, J. N. (1978) · Journal of Bacteriology · doi:10.1128/jb.135.2.460-465.1978 · Cited by 104
Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus
DeJonge, B. L. M., Sidow, T., Chang, Y. S., Labischinski, H., Berger‐Bächi, B., Gage, D. A., & Tomasz, A. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.9.2779-2782.1993 · Cited by 101
ENDOCARDITIS DUE TOCOAGULASE-NEGATIVE STAPHYLOCOCCI
Whitener, C., Caputo, G. M., Weitekamp, M. R., & Karchmer, A. W. (1993) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30507-9 · Cited by 98
DeJonge, B. L. M., Chang, Y. S., Gage, D. A., & Tomasz, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49904-3 · Cited by 97
Chambers, H. F. “., & Hackbarth, C. J. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1982 · Cited by 95
Self-citationHackbarth, C. J., Chambers, H. F. “., & Sande, M. A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.4.611 · Cited by 93
Self-citationMaki, H., Yamaguchi, T., & Murakami, K. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.16.4993-5000.1994 · Cited by 91
Watanakunakorn, C., & Tisone, J. C. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.5.903 · Cited by 91
Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization.
Mulligan, M. E., Ruane, P. J., Johnston, L., Wong, P., Wheelock, J. P., Macdonald, K. E., Reinhardt, J. F., Johnson, C. C., Statner, B., & Blomquist, I. K. (1987) · PubMed · Cited by 90
Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin
Greenberg, R. N., Kennedy, D. J., Reilly, P. M., Luppen, K. L., Weinandt, W. J., Bollinger, M., Aguirre, F., Kodesch, F., & Saeed, A. M. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.151 · Cited by 89
Miller, M. H., Wexler, M. A., & Steigbigel, N. H. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.3.336 · Cited by 85
Chambers, H. F. “. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1919 · Cited by 85
Self-citationThe Efficacy of Rifampin as Adjunctive Therapy in Selected Cases of Staphylococcal Endocarditis
Massanari, R. M., & Donta, S. T. (1978) · CHEST Journal · doi:10.1378/chest.73.3.371 · Cited by 85
Tesch, W., Ryffel, C., Strässle, A., Kayser, F. H., & Berger‐Bächi, B. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.9.1703 · Cited by 83
Hiramatsu, K., Kihara, H., & Yokota, T. (1992) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1992.tb02043.x · Cited by 80
Hürlimann-Dalel, R. L., Ryffel, C., Kayser, F. H., & Berger‐Bächi, B. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2617 · Cited by 79
Kang, S., Rybak, M. J., McGrath, B. J., Kaatz, G. W., & Seo, S. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.12.2702 · Cited by 76
Oxazolidinones: New antibacterial agents
Ford, C. W., Hamel, J. C., Stapert, D., Moerman, J. K., Hutchinson, D. K., Barbachyn, M. R., & Zurenko, G. E. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01032-9 · Cited by 75
Kaatz, G. W., Seo, S. M., Barriere, S. L., Albrecht, L. M., & Rybak, M. J. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1184 · Cited by 73
Differentiation of -Lactamase Variants of Staphylococcus aureus by Substrate Hydrolysis Profiles
Kernodle, D. S., Stratton, C. W., Mcmurray, L. W., Chipley, J. R., & McGraw, P. A. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.1.103 · Cited by 72
-Lactam Resistance Mechanisms of Methicillin-Resistant Staphylococcus aureus
Franciolli, M., Billé, J., Glauser, M. R., & Moreillon, P. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.3.514 · Cited by 71
Berger‐Bächi, B., Strässle, A., & Kayser, F. H. (1986) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02013308 · Cited by 70
Hiramatsu, K., Suzuki, E., Takayama, H., Katayama, Y., & Yokota, T. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.4.600 · Cited by 70
Clinical Study of Combination Therapy with Oxacillin and Rifampin for Staphylococcal Infections
van der Auwera, P., Meunier-Carpentier, F., & Klastersky, J. A. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s515 · Cited by 69
Gillespie, M. T., Lyon, B. R., Loo, L. S., Matthews, P., Stewart, P. R., & Skurray, R. A. (1987) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1987.tb02117.x · Cited by 64
Ornelas-Soares, A., de LENCASTRE, H., DeJonge, B. L. M., & Tomasz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46975-x · Cited by 63
Resistance heterogeneity in methicillin-resistantStaphylococcus aureus
Matthews, P., & Stewart, P. R. (1984) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1984.tb00718.x · Cited by 63
Genetic basis for molecular epidemiology of MRSA
Hiramatsu, K., Kondo, N., & Ito, T. (1996) · Journal of Infection and Chemotherapy · doi:10.1007/bf02351563 · Cited by 60
Intravenous trimethoprim-sulfamethoxazole in the treatment of serious infections in children
Ardati, K. O., Thirumoorthi, M. C., & Dajani, A. S. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80740-4 · Cited by 56
Impact of sar and agr on methicillin resistance in Staphylococcus aureus
Durán, S. P., Kayser, F. H., & Berger‐Bächi, B. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08394.x · Cited by 52
Minocycline as an Alternative Antistaphylococcal Agent
Yuk, J. H., Dignani, M. C., Harris, R. L., Bradshaw, M. W., & Williams, T. W. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.5.1023 · Cited by 51
Górgolas, M., Avilés, P., Verdejo, C., & Guerrero, M. L. F. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.953 · Cited by 50
Hanaki, H., Akagi, H., Masaru, Y., Otani, T., Hyodo, A., & Hiramatsu, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.5.1120 · Cited by 45
Novak, S., Hindler, J. F., & Bruckner, D. A. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.11.3056-3057.1993 · Cited by 36
Nicolau, D. P., Freeman, C. D., Nightingale, C. H., Coe, C. J., & Quintiliani, R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1515 · Cited by 35
Gustafson, J. E., & Wilkinson, B. J. (1989) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1989.tb03092.x · Cited by 28
DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCI
Chambers, H. F. “. (1993) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30530-4 · Cited by 27
Self-citationRobinson, L. W. (1960) · BMJ · doi:10.1136/bmj.1.5166.125-b · Cited by 22
Cited by
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Metadata
- Authors
- Chambers, H. F.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1997-10
- Volume
- 10
- Issue
- 4
- Pages
- 781-791
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2113091465
- Cited by
- 1,127
- References
- 100
- FWCI
- 18.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.